DMAC
DMAC

Diamedica Therapeutics Inc

NASDAQ · Biotechnology
$8.14
+0.60 (+7.96%)
Analyst Consensus
Strong Buy
11 analysts
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target -48.9% upside
Low Target $2.49
Average Target $4.16
High Target $4.48
Current Price $8.14
Current
$8.14
Target
$4.16
$2.49 $4.16 avg $4.48